financetom
Business
financetom
/
Business
/
PayPal, Venmo Users Receive Early Access to Perplexity's AI Browser Comet
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PayPal, Venmo Users Receive Early Access to Perplexity's AI Browser Comet
Sep 3, 2025 7:16 AM

09:43 AM EDT, 09/03/2025 (MT Newswires) -- PayPal ( PYPL ) said Wednesday that its customers and those of its Venmo unit will have early access to a Comet, a new AI-based browser that was developed by privately-owned tech company Perplexity.

Customers will be able to sign up for an offer that includes a free one-year trial of Perplexity Pro valued at $200, the company said.

Shares of PayPal ( PYPL ) were up 0.8% in recent early trading.

Price: 69.55, Change: +0.30, Percent Change: +0.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kazia Therapeutics' Phase 2/3 Trial for Paxalisib in Glioblastoma Brain Cancer Shows Clinically Significant Improvement
Kazia Therapeutics' Phase 2/3 Trial for Paxalisib in Glioblastoma Brain Cancer Shows Clinically Significant Improvement
Jul 10, 2024
08:32 AM EDT, 07/10/2024 (MT Newswires) -- Kazia Therapeutics ( KZIA ) said Wednesday a phase 2/3 trial has shown that its investigational brain disease treatment, paxalisib, causes clinically significant improvement in overall survival for patients with glioblastoma, a life-threatening brain cancer. Paxalisib showed an approximate 33% improvement in the overall survival of newly diagnosed patients with glioblastoma, compared with...
US regional banks to face increased scrutiny as CRE exposure stifles buybacks
US regional banks to face increased scrutiny as CRE exposure stifles buybacks
Jul 10, 2024
(Reuters) - U.S. regional banks will probably stockpile more rainy-day funds and stay conservative on stock buybacks as losses from commercial real estate (CRE) loans are expected to pressure their earnings, analysts said. As regional lenders prepare to report second-quarter results next week, they continue to face tough scrutiny from investors over potential weakness from CRE and commercial borrowers. Regional...
--HSBC Gets SVB Trade-Secret Lawsuit Trimmed Down
--HSBC Gets SVB Trade-Secret Lawsuit Trimmed Down
Jul 10, 2024
08:35 AM EDT, 07/10/2024 (MT Newswires) -- Price: 43.01, Change: +0.03, Percent Change: +0.07 ...
Virpax Says Non-Narcotic Pain Medication Shows Positive Results in Swine Model Study; Shares Rise
Virpax Says Non-Narcotic Pain Medication Shows Positive Results in Swine Model Study; Shares Rise
Jul 10, 2024
08:34 AM EDT, 07/10/2024 (MT Newswires) -- Virpax Pharmaceuticals ( VRPX ) on Wednesday reported positive results in a swine model pilot study of Probudur, the company's liposomal bupivacaine formulation to provide both immediate and extended pain relief. Probudur was injected into four juvenile domestic pigs at a dose of 30 mg per kilogram and was well-tolerated and demonstrated a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved